An allogeneic stem cell-derived transplant, OPC1 helps restore or increase the functional activity in SCI patients. It is tailored to replace the spinal cord cells that are either ...
More than 15 million people worldwide are living with spinal cord injury (SCI), which can affect their sensory and motor ...
Neurosurgeon Jocelyne Bloch, MD, and neuroscientist Grégoire Courtine, PhD, co-direct their lab, NeuroRestore, and are working to use artificial intelligence-driven implants to help spinal cord injury ...
Neuvotion announced today that it received FDA 510(k) clearance for its first product, the NeuStim wearable device.
Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic ...
Neuvotion has received FDA 510(k) clearance for their first product, NeuStim™, a non-invasive, surgery-free wearable that ...
Lineage Cell Therapeutics (LCTX) announced that the Company has initiated the DOSED clinical study. The DOSED study will evaluate the safety ...
A neurosurgeon and a neuroscientist discover promising new ways to help people with spinal cord injuries walk again ...
On the day of his out-patient procedure to remove a kidney stone, Chad Gerlaugh drove himself to Morton Plant Hospital in a ...
Three people with a muscle-destroying disease destined to worsen got a little stronger -- able to stand and walk more easily ...
The Sheltering Arms Institute recently employed innovative new technology that can help patients regain their independence.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback